�鶹Ů��

In a heated confirmation hearing that focused on ethical issues, President Trump’s nominee for secretary of health and human services, Representative Tom Price, defended his trading of medical and pharmaceutical stocks on Tuesday, saying, “Everything that I did was ethical, aboveboard, legal and transparent.” Democrats accused Mr. Price of a potential conflict of interest at a hearing of the Senate Finance Committee, saying he held more than $100,000 in stock in companies that could have benefited from legislation he promoted. Mr. Price, a Georgia Republican, denied any wrongdoing. (Pear and Kaplan, 1/24)

Democrats began a key hearing on President Donald Trump’s pick to overhaul Obamacare by attacking his aggressive investing in health-care companies, an attempt to derail the nomination by hammering on ethics even though Republicans can force a confirmation with a party-line vote. Senator Ron Wyden, the top Democrat on the Finance Committee, slammed Georgia Representative Tom Price’s “abuse of his position” by buying privately offered shares in Innate Immunotherapeutics Ltd. as Congress weighed bills that could affect his investments. Democrats need to persuade Republicans on the panel to oppose Price in order to block his appointment as secretary of the Department of Health and Human Services; so far they have defended Price, and none have indicated they’d vote him down. (Edney and Tracer, 1/24)

President Donald Trump's selection to become health secretary told a Senate committee Tuesday that the new administration believes people with existing illnesses should not be denied health insurance, but committed to no details on that or any aspects of how Republicans will reshape President Barack Obama's health care law. Rep. Tom Price, R-Ga., who would be at the center of GOP efforts to scuttle Obama's statute and create new programs, frustrated Democrats probing for details of what Republicans will do. Instead, he repeatedly told them that the GOP goal is making health care affordable and "accessible for every single American" and to provide choices. (Fram and Alonso-Zaldivar, 1/24)

[Price] told a congressional panel on Tuesday that he does not support the privatization of Medicare and defended his ethics record. Speaking before the Senate Committee on Finance, one of two committees that oversee the health department, Representative Tom Price said his position was consistent with that of Trump, who has stated he does not want to cut the federal health program for the elderly. (Clarke and Cornwell, 1/24)

“The Medicare trustees … have told all of us that Medicare, in a very short period of time, less than 10 years, is going to be out of the kind of resources that will allow us as a society to keep the promise to beneficiaries,” Price said Tuesday before the Senate Finance Committee. “We will not be able to provide the services to Medicare patients at that time — which is very, very close — if nothing is done.” (McIntire, 1/24)

President Trump’s choice for health secretary declined Tuesday to promise that no Americans would be worse off under Trump’s executive order to ease provisions of the Affordable Care Act — and distanced himself from the president’s claim to have an almost-finished plan to replace the law. At a testy Senate confirmation hearing on his nomination to lead the Department of Health and Human Services, Rep. Tom Price (R-Ga.) sought to play down the influence he would have on reshaping the health-care system along conservative lines, while attempting to deflect accusations from Democrats about his ethics. (Goldstein and Eilperin, 1/24)

The nominee to head HHS wouldn’t say if he would use the directive to scrap Obamacare’s unpopular requirement that most Americans get health coverage or pay a fine. Price also dodged questions about whether he backs converting Medicaid into block grants, despite supporting the idea as House Budget Committee chairman. And he gave vague assurances he wouldn’t “abandon” people with pre-existing conditions who can no longer be denied coverage under Obamacare while disputing a 2012 report that quoted him criticizing the law's requirement that insurers cover that population. (Cancryn, 1/24)

Democrats argued that Price's approach would result in many Americans losing their access to medical care. Lawmakers and Price tussled intensely over the future of Medicaid, which serves more than 70 million people, or more than one-fifth of the U.S. population. Sen. Maria Cantwell, D-Wash., said the Trump administration appears to be “creating a war on Medicaid,” referring to recent comments such as those from the president’s senior adviser Kellyanne Conway in favor of block grants. (Young, 1/24)

Democrats on the finance panel repeatedly quizzed Price about what would happen to patients. Price kept his answers vague. In a round of questions about Medicare, Sen. Bob Menendez  (D-N.J.) asked: “Are you willing to commit that we won’t see increased costs or less coverage for seniors under a revision of Medicare that you might advocate or that the president might pursue?” Price responded: “Our goal is to make certain that seniors have access to the highest quality healthcare possible at an affordable price.” (Levey, 1/24)

Mr. Trump has sent sometimes conflicting messages about the stamp he intends to place in shaping the debate over repealing the ACA, urging Congress to act quickly but also saying he has his own plan that he intends to release soon. Mr. Price declined to say whether he would hold back on acting on Mr. Trump’s executive action until Republicans had coalesced around any replacement for the law. Asked by Democratic Sen. Michael Bennet of Colorado if Republicans’ proposals to repeal the ACA also included repealing the law’s expansion of Medicaid, he replied: “I, if I’m fortunate to serve as the Secretary of Health and Human Services, will carry out the law that you pass. That’s a decision that you all will make.” (Radnofsky and Armour, 1/24)

Rep. Tom Price refused to say how aggressively he'll implement President Donald Trump's order instructing federal agencies to pare back Obamacare — and he refused to promise that Obamacare enrollees wouldn't lose coverage as a result of the order. (Pradhan and Demko, 1/24)

Trump's pick, Rep. Tom Price, R-Ga., sounded unfamiliar with the legislation that Trump said would be released after Price is confirmed by the Senate when he was asked about it by Sen. Sherrod Brown, D-Ohio, during his confirmation hearing before the Senate Finance Committee. "It’s true that he said that," Price said to laughter. "I’ve had conversations with the president about health care." (O'Donnell, 1/24)

The question of what to do with Medicaid -- particularly how to handle the low-income adults who gained coverage thanks to Obamacare's expansion provision -- came up repeatedly during the hearing. Trump senior adviser Kellyanne Conway said Sunday on ABC News that the president is looking at turning Medicaid into a block grant program. (Luhby, 1/25)

President Donald Trump’s administration made explicit this weekend its commitment to an old GOP strategy for managing Medicaid, the federal-state insurance plan that covers low-income people — turning control of the program to states and capping what the federal government spends on it each year. It’s called “block granting.” ... But what would this look like, and why is it so controversial? Let’s break down how this policy could play out, and its implications — both for government spending and for accessing care. (Luthra, 1/24)

When asked about the CMS Innovation Center, he said that it had gotten “off track” but could be a tool for improving healthcare with programs that do not mandate provider participation. He later said that “for certain payment populations, bundled payments make a lot of sense.” (Muchmore, 1/24)

Rep. Tom Price (R-Ga.), President Donald Trump’s nominee to lead the Department of Health and Human Services, suggested he would want to preserve a Medicare and Medicaid innovation lab created in the Obama administration. Price told the Senate Finance Committee on Tuesday that innovation is important to medicine, and that the Center for Medicare and Medicaid Innovation “is a vehicle that might” support innovation. The CMMI was created under the Affordable Care Act to test new ways of delivering health care, with the goal of increasing quality and lowering costs. (McIntire, 1/24)

Not a single Democrat has said they will vote for Price, raising the possibility that he could be the first member of President Trump's Cabinet to be approved on a strict party-line vote. (Sullivan and Hellmann, 1/24)

Despite some withering criticism from Democrats about his stock trades and questions about Price’s plans for the health law, Republicans appear to be solidly supporting Price. (1/24)

Social Security, Medicare and Medicaid need significant changes to be preserved for future generations, President Donald Trump's pick to head the White House budget office told Congress Tuesday. Rep. Mick Mulvaney's comments at his confirmation hearing stand in sharp contrast to Trump's campaign pledges not to cut the programs. (Ohlemacher, 1/24)